Fully Automated Open-source Lesion Mapping of T2-FLAIR Images with FSL Correlates with Clinical Disability in MS

Overview

Journal Brain Behav

Specialty Psychology

Date 2016 Feb 9

PMID 26855828

Citations 7

Authors

Nathan C Wetter

Elizabeth A Hubbard

Robert W Motl

Bradley P Sutton

Affiliations

Soon will be listed here.

Abstract

Background: T2 Lesion Volume (T2LV) has been an important biomarker for multiple sclerosis (MS). Current methods available to quantify lesions from MR images generally require manual adjustments or multiple images with different contrasts. Further, implementations are often not easily or openly accessible.

Objective: We created a fully unsupervised, single T2 FLAIR image T2LV quantification package based on the popular open-source imaging toolkit FSL.

Methods: By scripting various processing tools in FSL, we developed an image processing pipeline that distinguishes normal brain tissue from CSF and lesions. We validated our method by hierarchical multiple regression (HMR) with a preliminary study to see if our T2LVs correlate with clinical disability measures in MS when controlled for other variables.

Results: Pearson correlations between T2LV and Expanded Disability Status Scale (EDSS: r = 0.344, P = 0.013), Six-Minute Walk (6MW: r = -0.513, P = 0.000), Timed 25-Foot Walk (T25FW: r = -0.438, P = .000), and Symbol Digit Modalities Test (SDMT: r = -0.499, P = 0.000) were all significant. Partial correlations controlling for age were significant between T2LV and 6MW (r = -0.433, P = 0.002), T25FW (r = -0.392, P = 0.004), and SDMT (r = -0.450, P = 0.001). In HMR, T2LV explained significant additional variance in 6MW (R(2) change = 0.082, P = 0.020), after controlling for confounding variables such as age, white matter volume (WMV), and gray matter volume (GMV).

Conclusion: Our T2LV quantification software produces T2LVs from a single FLAIR image that correlate with physical disability in MS and is freely available as open-source software.

Citing Articles

Yoga, aerobic and stretching exercise effects on neurocognition: Randomized controlled trial protocol.

Gothe N, Erlenbach E, Garcia V, Malani R, Voss S, Camacho P Contemp Clin Trials. 2023; 131:107240.

PMID: 37244365 PMC: 10527553. DOI: 10.1016/j.cct.2023.107240.

Nonparenchymal fluid is the source of increased mean diffusivity in preclinical Alzheimer's disease.

Sepehrband F, Cabeen R, Barisano G, Sheikh-Bahaei N, Choupan J, Law M Alzheimers Dement (Amst). 2019; 11:348-354.

PMID: 31049392 PMC: 6479267. DOI: 10.1016/j.dadm.2019.03.002.

Analytic Tools for Post-traumatic Epileptogenesis Biomarker Search in Multimodal Dataset of an Animal Model and Human Patients.

Duncan D, Barisano G, Cabeen R, Sepehrband F, Garner R, Braimah A Front Neuroinform. 2019; 12:86.

PMID: 30618695 PMC: 6307529. DOI: 10.3389/fninf.2018.00086.

Brain imaging of locomotion in neurological conditions.

Allali G, Blumen H, Devanne H, Pirondini E, Delval A, Van De Ville D Neurophysiol Clin. 2018; 48(6):337-359.

PMID: 30487063 PMC: 6563601. DOI: 10.1016/j.neucli.2018.10.004.

Occulomotor Neural Integrator Dysfunction in Multiple Sclerosis: Insights From Neuroimaging.

Bede P, Finegan E, Chipika R, Shing S, Lambe J, Meaney J Front Neurol. 2018; 9:691.

PMID: 30190700 PMC: 6116658. DOI: 10.3389/fneur.2018.00691.

References

Griswold M, Jakob P, Heidemann R, Nittka M, Jellus V, Wang J . Generalized autocalibrating partially parallel acquisitions (GRAPPA). Magn Reson Med. 2002; 47(6):1202-10. DOI: 10.1002/mrm.10171. View

Cohen A, Neema M, Arora A, DellOglio E, Benedict R, Tauhid S . The relationships among MRI-defined spinal cord involvement, brain involvement, and disability in multiple sclerosis. J Neuroimaging. 2011; 22(2):122-8. PMC: 3128174. DOI: 10.1111/j.1552-6569.2011.00589.x. View

Goldman M, Marrie R, Cohen J . Evaluation of the six-minute walk in multiple sclerosis subjects and healthy controls. Mult Scler. 2007; 14(3):383-90. DOI: 10.1177/1352458507082607. View

Polman C, Reingold S, Banwell B, Clanet M, Cohen J, Filippi M . Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria. Ann Neurol. 2011; 69(2):292-302. PMC: 3084507. DOI: 10.1002/ana.22366. View

Smith S, Zhang Y, Jenkinson M, Chen J, Matthews P, Federico A . Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage. 2002; 17(1):479-89. DOI: 10.1006/nimg.2002.1040. View

Goodman A, Brown T, Krupp L, Schapiro R, Schwid S, Cohen R . Sustained-release oral fampridine in multiple sclerosis: a randomised, double-blind, controlled trial. Lancet. 2009; 373(9665):732-8. DOI: 10.1016/S0140-6736(09)60442-6. View

Smith S, Jenkinson M, Woolrich M, Beckmann C, Behrens T, Johansen-Berg H . Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage. 2004; 23 Suppl 1:S208-19. DOI: 10.1016/j.neuroimage.2004.07.051. View

Jenkinson M, Bannister P, Brady M, Smith S . Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage. 2002; 17(2):825-41. DOI: 10.1016/s1053-8119(02)91132-8. View

Sormani M, Bonzano L, Roccatagliata L, De Stefano N . Magnetic resonance imaging as surrogate for clinical endpoints in multiple sclerosis: data on novel oral drugs. Mult Scler. 2010; 17(5):630-3. DOI: 10.1177/1352458510393770. View

10.

Sormani M, Bruzzi P . MRI lesions as a surrogate for relapses in multiple sclerosis: a meta-analysis of randomised trials. Lancet Neurol. 2013; 12(7):669-76. DOI: 10.1016/S1474-4422(13)70103-0. View

11.

Bonneville F, Moriarty D, Li B, Babb J, Grossman R, Gonen O . Whole-brain N-acetylaspartate concentration: correlation with T2-weighted lesion volume and expanded disability status scale score in cases of relapsing-remitting multiple sclerosis. AJNR Am J Neuroradiol. 2002; 23(3):371-5. PMC: 7975304. View

12.

Benedict R, Cookfair D, Gavett R, Gunther M, Munschauer F, Garg N . Validity of the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc. 2006; 12(4):549-58. DOI: 10.1017/s1355617706060723. View

13.

Llado X, Ganiler O, Oliver A, Marti R, Freixenet J, Valls L . Automated detection of multiple sclerosis lesions in serial brain MRI. Neuroradiology. 2011; 54(8):787-807. DOI: 10.1007/s00234-011-0992-6. View

14.

Mammi S, Filippi M, Martinelli V, Campi A, Colombo B, Scotti G . Correlation between brain MRI lesion volume and disability in patients with multiple sclerosis. Acta Neurol Scand. 1996; 94(2):93-6. DOI: 10.1111/j.1600-0404.1996.tb07036.x. View

15.

Paniagua Bravo A, Sanchez Hernandez J, Ibanez Sanz L, Alba de Caceres I, Crespo San Jose J, Garcia-Castano Gandariaga B . A comparative MRI study for white matter hyperintensities detection: 2D-FLAIR, FSE PD 2D, 3D-FLAIR and FLAIR MIP. Br J Radiol. 2014; 87(1035):20130360. PMC: 4064604. DOI: 10.1259/bjr.20130360. View

16.

Kearney H, Rocca M, Valsasina P, Balk L, Sastre-Garriga J, Reinhardt J . Magnetic resonance imaging correlates of physical disability in relapse onset multiple sclerosis of long disease duration. Mult Scler. 2013; 20(1):72-80. PMC: 4107776. DOI: 10.1177/1352458513492245. View

17.

Motl R, Weikert M, Suh Y, Sosnoff J, Pula J, Soaz C . Accuracy of the actibelt(®) accelerometer for measuring walking speed in a controlled environment among persons with multiple sclerosis. Gait Posture. 2011; 35(2):192-6. DOI: 10.1016/j.gaitpost.2011.09.005. View

18.

Zhang Y, Brady M, Smith S . Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans Med Imaging. 2001; 20(1):45-57. DOI: 10.1109/42.906424. View

19.

Batista S, Zivadinov R, Hoogs M, Bergsland N, Heininen-Brown M, Dwyer M . Basal ganglia, thalamus and neocortical atrophy predicting slowed cognitive processing in multiple sclerosis. J Neurol. 2011; 259(1):139-46. DOI: 10.1007/s00415-011-6147-1. View

20.

Bonati U, Fisniku L, Altmann D, Yiannakas M, Furby J, Thompson A . Cervical cord and brain grey matter atrophy independently associate with long-term MS disability. J Neurol Neurosurg Psychiatry. 2010; 82(4):471-2. DOI: 10.1136/jnnp.2010.205021. View